Loading...

PRIMARY CERVICAL CANCER SCREENING HIGH RISK HPV DETECTION

image not found

 NABL Cap Accredited 
The Primary Cervical Cancer Screening for High-Risk HPV Detection at Metropolis Healthcare is an advanced molecular test designed to identify high-risk human papillomavirus types associated with cervical cancer. This screening helps detect infections that may lead to precancerous changes long before symptoms appear. It is a highly sensitive method recommended for routine cervical cancer prevention. Metropolis Healthcare uses validated PCR-based technology to deliver accurate and clinically reliable results for early risk assessment

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 2,600.00

Sample Type: Vaginal Swab

Fasting Not Required


Notes:P8566

Frequently Asked Questions (FAQ's):

 What does the High-Risk HPV Detection test include?

It identifies high-risk HPV strains known to cause cervical cancer, offering early insight into cervical health.

How does Metropolis Healthcare perform this screening?
The test is conducted using advanced PCR-based methods that precisely detect high-risk HPV DNA.

Who should undergo this cervical cancer screening?
Women aged 25 and above, or those advised by a gynecologist for routine screening or follow-up.

Do I need to fast before the test?
No fasting is required; however, it is recommended to avoid intercourse, douching, or vaginal creams for 24–48 hours before sample collection.

Can this test detect cervical cancer directly?
It does not diagnose cancer but identifies high-risk HPV infections that may lead to precancerous or cancerous changes.

How soon will Metropolis Healthcare provide the results?
Results are typically available within the standard reporting time for molecular HPV tests.

Is this test more accurate than a Pap smear?
High-risk HPV testing is more sensitive for detecting early cervical risk, and many guidelines recommend it as a primary screening tool.

Can this test be used for monitoring after treatment?
Yes, it helps track the clearance or persistence of high-risk HPV infections during follow-up care

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab